3.440SEK+9.21%Mkt Cap: 367.04M SEKP/E: —Last update: 2026-05-13
Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activa…
Industry Peers
Medical Instruments & Suppliesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)6.02
PEG—
P/B6.24
P/S4.41
EV/EBITDA-53.93
EV/Revenue3.63
EPS (TTM)-0.17
EPS (Forward)0.61
Cash Flow & Leverage
FCF Yield-2.95%
FCF Margin-13.01%
Operating CF-18.81M SEK
CapEx (TTM)404.00K SEK
Net Debt/EBITDA7.36
Net Debt-41.26M SEK
Technical
SMA 503.257 (+5.6%)
SMA 2002.823 (+21.9%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)65.67K
Avg Vol (10d)53.10K
Technical Indicators
RSI (14)60.4
MACD-0.0192
MACD Signal-0.0325
MACD Hist.+0.0133
BB Upper3.392 SEK
BB Middle3.196 SEK
BB Lower2.999 SEK
BB Width12.29%
ATR (14)0.2586 SEK
Vol Ratio (20d)1.23x
52W Range
1.15080% of range4.000
52W High4.000 SEK
52W Low1.150 SEK
Profitability
Gross Margin76.48%
EBITDA Margin-6.73%
Profit Margin-24.39%
Oper. Margin14.06%
ROE-30.99%
ROA-21.55%
Revenue Growth228.00%
Earnings Growth—
Balance Sheet
Debt/Equity—
Current Ratio4.43
Quick Ratio3.27
Book Value/Sh0.5880 SEK
Cash/Share0.4410 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.100.01M
Float41.95M
Insiders34.25%
Institutions10.68%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap367.04M SEK
Enterprise Value302.11M SEK
Revenue (TTM)83.23M SEK
Gross Profit47.81M SEK
Net Income (TTM)-15.25M SEK
Revenue/Share0.9650 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees31
Last Price3.440 SEK
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—